Syndax Pharmaceuticals, Inc. ($SNDX)
Filing Information
| Accession Number | 0001193125-26-041500 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 6, 2026 |
| Document Date | Feb 4, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
665,012
Total Value
$9,142,035.44
P&L
+77.8% (+$6,990,480.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 4, 2026 | Grant/Award | 73,000 | $0.00 | $0.00 | 371,661 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 4, 2026 | Grant/Award | 144,600 | $0.00 | $0.00 | 516,261 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 6, 2026 | Sale | 7,412 | $20.62 | $152,835.44 | 508,849 | Direct | โ | View Details | |
Director | Stock Options (Right to buy) | Derivative | Feb 4, 2026 | Grant/Award | 440,000 | $20.43 | $8,989,200.00 | 440,000 | Direct | โ | View Details |